![](/__local/5/C6/15/0B19FBD7BE0D2784983B7CA08CD_8F0AB116_50594.png)
职 称:讲师
学 历:博士
E-mail:xxlynne@Gmail.com
研究方向:小分子药物的肿瘤靶向治疗,药理研究;药物递送介质开发;生物传感
工作经历:
1999/09-2003/07 兰州大学本科,大化学学士
2003/09-2004/12 英国诺丁汉Trent大学研究生,应用生物学硕士
2006/03-2009/11英国伍尔玆汉普顿大学RIHS研究生,生物医学博士学位
2009/03- 2009/12 英国卡迪夫大学医学院生物医学研究中心
2010/01-2016/01 英国诺丁汉大学药学院生物科学研究中心
2016/06-2019/07 肽泽(武汉)生物科技有限公司
2020/07-至今,湖北工业大学
研究课题:
Targeting Nuclear factor-kappaB pathway to improve chemotherapy of breast cancer
Targeting the nuclear-kappaB(NF-кB)pathway to improve chemotherapy of glioblastoma multiforme
Small molecular blockers of the protein interaction between AnnexinA2 and S100 proteins
人源性穿膜肽的开发和应用研究
研究成果:
1)Bing Xu*, Xiaoxia Guo*, Sumi Mathew, Angel L Armesilla, James Cassidy, John L Darling, Weiguang Wang, Triptolide simultaneously induces reactive oxygen species, inhibits NF-κB activity and sensitizes 5-fluorouracil in colorectal cancer cell lines. Cancer Letters 2010; 291: 200-8 (*joint first authors)
2)Xiaoxia Guo, Shuchita Pandey, Bing Xu, Weiguang Wang, Disulfiram/copper complex inhibiting NF-κB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer Letters 2010; 290: 104-13
3)Xiaoxia Guo, Elisabeth Goessl, Elaina S.R. Collie-Duguid, James Cassidy, Vincent O’brien. Cell Cycle Perturbation and Acquired 5-Fluoracil Chemoresistance. Anticancer Research 2008; 28: 9-14
4)Xiaoxia Guo, Jeff Evans, Angel Armesilla, John Darling, Andreas Schatzlein, James Cassidy, Weiguang Wang. In vitro evaluation of cancer specific NF-κB-CEA enhancer-promoter system for gene-directed enzyme prodrug therapy in colon cancer cell lines. British Journal of Cancer 2007; 97: 745-54
5)Helene K Myrvang, Xiaoxia Guo, Chan Li and Lodewijk V Dekker. Protein interactions between surface Annexin A2 and S100A10 mediate adhesion of breast cancer cells to .17microvascular endothelial cells. FEBS 2013; 587(19),3210-3215